Trial Profile
A Phase I, Randomised, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Gerilimzumab when Administered Subcutaneously to Healthy Adult Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Gerilimzumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Bird Rock Bio
- 18 Mar 2016 New trial record
- 16 Mar 2016 Results published in Bird Rock Bio's media release.